Patent ID: 8900605

Claim:
A solid composition containing ivabradine or a pharmaceutically acceptable salt thereof as active substance in combination with at least one pharmaceutically acceptable excipient characterized in that the excipient and the active substance are present in the form of a solid solution, wherein the pharmaceutically acceptable excipient is selected from the group consisting of sucrose, sorbitol, xylitol, polyethylene glycol, polyoxyethylene glycol monostearate, glycerol polyethylene glycol ricinolate, macrogol glycerol stearate, glycerol palmitol stearate, macrogol glycerol laurate, polyethylene glycol cetylstearyl ether, glycerol monostearate, polyvinylpyrrolidone, hydroxypropylmethylcellulose (HPMC), carboxymethylcellulose (CMC), ethylcellulose, methylcellulose (MC), hydroxyethylcellulose, ethylhydroxyethylcellulose, hydroxypropylcellulose (HPC), micro-crystalline cellulose, cellulose ethers, copovidone, and ethylene oxide-propylene oxide block-copolymers, further wherein the weight ratio of active substance, based on the free base, to excipient is in the range of 1:10 to 1:1,000.